07:24 AM EDT, 08/11/2025 (MT Newswires) -- Legend Biotech ( LEGN ) reported Q2 adjusted earnings Monday of $0.03 per diluted share, swinging from a loss of $0.01 a year earlier.

Comparable estimates were not available.

Total revenue for the quarter ended June 30 was $255.1 million, compared with $186.5 million a year earlier.

Analysts polled by FactSet expected $228 million.

Shares of the company were up 2% in recent Monday premarket activity.